Anavex Life Sciences Corp (AVXL)

[nidan7500]

see bear msg.

Anavex says about a2-73:
“The drug candidate has the potential to restore the molecular balance of cells by targeting misfolded proteins and mitochondria dysfunction. This ultimately prevents oxidative stress, inflammation, and cellular stress, processes that are shared by many neurological disorders and known to contribute for nerve cell degeneration.”

IMO, the upcoming AD A2-73 trials are all about validation of this claim above. No more, no less. When that happens a true medical binary event will be witnessed. Of course there are likely to be discussion of degree and other uncertainties to follow.

We also expect to see RWE on.."[quoteA2-73 AS A THERAPEUTIC FOR INSOMNIA, ANXIETY, AND AGITATION” ]